TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
LENZ

LENZ Therapeutics Inc

Healthcare · Biotechnology

3.60$ -5.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LENZ
Line item 2019 2020 2021 2022 2023 2024 2025
– +375,966.7% -18.7% +156.1% +49.9% +205.9% +42.1%
– +351,616.7% -13.2% +154.5% +44.2% +215.1% +42.2%
– +330,183.3% -7.6% +142.8% -20.9% -42.6% +24.9%
– +330,183.3% -7.6% +142.8% +48.0% +217.7% +39.9%
– – – – – – –
– – – – – – –
– +1,355.2% +0.6% +118.5% +129.3% -93.1% +92.0%
– +1,341.0% -96.1% +658.1% +94.9% -43.8% +103.6%
– – – – +33.0% +313.9% -18.0%
– – -27.0% +933.7% +20.1% -25.5% -2.1%
– – – – – – +39.3%
– – – – – – –
– +0.0% -0.1% -5.4% +3.9% +161.3% +35.4%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?